JPRN-UMIN000012322已完成未知
Early evaluation for chemotherapy response of lung cancer using a new PET/CT tracer of DNA synthesis. - 4DST PET/CT for lung cancer chemotherapy
ational Center for Global Health and Medicine0 个研究点目标入组 80 人开始时间: 2013年11月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Those who have not signed the informed consent form. Those who have symptomatic brain metastasis, or active double cancer, or active infectious disease, or spinal metastasis that required immediate surgery or radiotherapy, or uncontrollable hypertension, or ischemic heart disease, or uncontrollable diabetes. Those who have been decided not appropriate by the physician.
研究者
相似试验
终止
不适用
Assessing the role of Positron Emission Tomography (PET) scanning to assess early response to treatment in advanced breast cancer.Breast CancerACTRN12612001044819Alfred Foundation5
招募中
不适用
Early response evaluation of chemotherapy in malignant lymphoma by contrast-enhanced ultrasonographymalignant lymphomaJPRN-UMIN000024619ihon University School of Medicine, Itabashi Hospital50
进行中（未招募）
1 期
A new magnetic resonance scanning technology for monitoring therapy effects in patients with Pancreatic cancer.MedDRA version: 20.0Level: LLTClassification code 10033575Term: Pancreas cancerSystem Organ Class: 100000004864EUCTR2016-004491-22-DKDept. Clinical Medicine, Aarhus Universit15
已完成
不适用
Early response assessment of induction chemotherapy in acute myeloid leukemia patients using F-18 fluorodeoxythymidine (FLT) positron emission tomography (PET)/computed tomogrpahy (CT)Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0001293The Catholic University of Korea, St. Vincent's Hospital13
已完成
2 期
Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.Lung CancerNCT00226577H. Lee Moffitt Cancer Center and Research Institute52